The primary aim for this study is to investigate the safety and tolerability of the AZD1704, first time in man.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Masking
QUADRUPLE
Enrollment
80
One dose, by mouth
Reserach Site
Macclesfield, Cheshire, United Kingdom
To investigate the safety and tolerability of AZD1704 following single ascending doses in healthy volunteers.
Time frame: At screening, during residential period (daily) and at follow-up
To investigate the subjective CNS effects of specific adjectives (stimulated, anxious, sedated, down and high) rated on visual analogue mood scale (VAMS).
Time frame: During residential period (daily)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.